IMPURITIES AVAILABLE FOR 'Cangrelor'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Cangrelor. Cangrelor is an intravenous, reversible P2Y12 receptor antagonist used as an antiplatelet agent. It works by blocking ADP-induced platelet activation and aggregation, thereby reducing the risk of thrombotic events. Cangrelor has a very rapid onset of action and a short half-life, making it suitable for use during percutaneous coronary intervention (PCI) when immediate platelet inhibition is required. It provides consistent and predictable antiplatelet effects compared to oral agents. The drug is particularly useful in patients who are unable to take oral P2Y12 inhibitors or require urgent platelet inhibition. Its effects wear off quickly after discontinuation, allowing platelet function recovery within an hour. Clinical trials have shown its benefit in reducing ischemic complications during PCI without significantly increasing major bleeding risks. Common side effects include bleeding and, less frequently, dyspnea. Buy high quality Cangrelor from Omsynth Lifesciences.